These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 2423613)
21. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of interleukin 2 vs B cell growth factor on human B cells. Nakagawa T; Nakagawa N; Ambrus JL; Fauci AS J Immunol; 1988 Jan; 140(2):465-9. PubMed ID: 2447179 [TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M; Iwato K; Kuramoto A J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108 [TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907 [TBL] [Abstract][Full Text] [Related]
25. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells. Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419 [TBL] [Abstract][Full Text] [Related]
26. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents. Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369 [TBL] [Abstract][Full Text] [Related]
27. The characterization of a human B cell line utilizable for the assay of B cell growth factors. Warrington RJ J Immunol Methods; 1987 Jun; 100(1-2):117-22. PubMed ID: 3110293 [TBL] [Abstract][Full Text] [Related]
28. Role of DNA synthesis in secretion of immunoglobulin from murine B cells stimulated by T cell derived lymphokines. Simpson LG; Isakson PC J Immunol; 1986 Sep; 137(6):1797-802. PubMed ID: 3091690 [TBL] [Abstract][Full Text] [Related]
29. Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro. Aguilar-Santelises M; Mellstedt H; Jondal M Leukemia; 1994 Jul; 8(7):1146-52. PubMed ID: 8035606 [TBL] [Abstract][Full Text] [Related]
30. Characterization of human B cell growth factor (BCGF) from cloned T cells or mitogen-stimulated T cells. Yoshizaki K; Nakagawa T; Fukunaga K; Kaieda T; Maruyama S; Kishimoto S; Yamamura Y; Kishimoto T J Immunol; 1983 Mar; 130(3):1241-6. PubMed ID: 6600479 [TBL] [Abstract][Full Text] [Related]
31. Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I. Kehrl JH; Muraguchi A; Fauci AS Eur J Immunol; 1984 Feb; 14(2):115-21. PubMed ID: 6199210 [TBL] [Abstract][Full Text] [Related]
32. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF). Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243 [TBL] [Abstract][Full Text] [Related]
33. Regulation of the IgM and IgA anti-dextran B1355S response: synergy between IFN-gamma, BCGF II, and IL 2. Murray PD; Swain SL; Kagnoff MP J Immunol; 1985 Dec; 135(6):4015-20. PubMed ID: 2415594 [TBL] [Abstract][Full Text] [Related]
34. Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. Chatenoud L; Dugas B; Beaurain G; Touam M; Drueke T; Vasquez A; Galanaud P; Bach JF; Delfraissy JF Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7457-61. PubMed ID: 3094009 [TBL] [Abstract][Full Text] [Related]
35. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Lasky JL; Thorbecke GJ Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224 [TBL] [Abstract][Full Text] [Related]
36. Differential response of malignant human B-cells to anti-IgM immunoglobulin (anti-mu) and B-cell growth factor: unique direct cytotoxicity of anti-mu on prolymphocytic leukemia cells. Chan CS; Soehnlen F; Schechter GP Blood; 1990 Oct; 76(8):1601-6. PubMed ID: 2119832 [TBL] [Abstract][Full Text] [Related]
37. IgM and IgG secretion in human B-cell lines regulated by B-cell-inducing factors (BIF) and phorbol ester. Ralph P; Saiki O; Maurer DH; Welte K Immunol Lett; 1983; 7(1):17-23. PubMed ID: 6605913 [TBL] [Abstract][Full Text] [Related]
38. Low molecular weight B cell growth factor induces proliferation of human B cell precursor acute lymphoblastic leukemias. Wörmann B; Mehta SR; Maizel AL; LeBien TW Blood; 1987 Jul; 70(1):132-8. PubMed ID: 2954597 [TBL] [Abstract][Full Text] [Related]
39. Human BCGF-12kD functions as an autocrine growth factor in transformed B cells. Kumar A; Vasquez A; Maizel AL; Sharma S Eur Cytokine Netw; 1990; 1(2):109-13. PubMed ID: 1966378 [TBL] [Abstract][Full Text] [Related]
40. Activation and immunoregulation of human B lymphocytes. Kehrl JH; Muraguchi A; Falkoff RJ; Ambrus JL; Butler JL; Fauci AS Uremia Invest; 1984-1985; 8(3-4):157-66. PubMed ID: 6085841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]